Literature DB >> 1834101

Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo.

C Feldman1, N C Munro, P K Jeffery, T J Mitchell, P W Andrew, G J Boulnois, D Guerreiro, J A Rohde, H C Todd, P J Cole.   

Abstract

Streptococcus pneumoniae infections are common, but how they cause host tissue injury and death is incompletely understood. Immunization with pneumolysin, a thiol-activated toxin produced by the pneumococcus, partially protects animals during subsequent infection. The mechanism by which pneumolysin contributes to disease is not known. The aim of the present investigation was to determine the histologic changes induced by recombinant pneumolysin in the rat lung and to compare them with the changes induced by live organisms. Injection of either toxin (200 or 800 ng) or bacteria into the apical lobe bronchus was associated with the development of a severe lobar pneumonia restricted to the apical lobe. The changes induced by the toxin were greater at the higher concentration, and changes were most severe in those animals in which there was partial ligation of the apical lobe bronchus. The pneumonitis was less severe following injection of a modified toxin with decreased hemolytic activity, generated by site-directed mutagenesis of the cloned pneumolysin gene, indicating that this property of the toxin was important in generating pulmonary inflammation. There was still considerable pneumonitis after injection of a modified toxin with decreased capacity to activate complement.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1834101     DOI: 10.1165/ajrcmb/5.5.416

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  37 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Sensitivities of human monocytes and epithelial cells to pneumolysin are different.

Authors:  Robert A Hirst; Hasan Yesilkaya; Edwin Clitheroe; Andrew Rutman; Nichola Dufty; Timothy J Mitchell; Christopher O'Callaghan; Peter W Andrew
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 3.  Bacteraemic pneumococcal pneumonia: current therapeutic options.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 4.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

5.  Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces.

Authors:  Adam J Ratner; Elena S Lysenko; Marina N Paul; Jeffrey N Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

6.  Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.

Authors:  Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

7.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 8.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

9.  Pneumolysin activates neutrophil extracellular trap formation.

Authors:  J G Nel; A J Theron; C Durandt; G R Tintinger; R Pool; T J Mitchell; C Feldman; R Anderson
Journal:  Clin Exp Immunol       Date:  2016-03-02       Impact factor: 4.330

10.  Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice.

Authors:  Mark C Dessing; Robert A Hirst; Alex F de Vos; Tom van der Poll
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.